Why this project qualifies
With $200 million in facility-specific investment and 100 permanent operating jobs announced, this project clears both of AFT's qualifying thresholds ($100 million in facility-specific investment OR 100 permanent operating jobs). This project also meets AFT's primary-source verification and physical U.S. manufacturing-footprint requirements.
View full methodology →Why it matters
The medical devices & diagnostics context.
Medical Devices & Diagnostics tracks qualifying U.S. factories producing medical devices, diagnostic instruments, testing systems, drug-delivery devices, vision-care products, and related regulated healthcare equipment. Pharmaceutical drug production remains in AFT's dedicated Pharmaceuticals category.
Project record
At a glance
- Company
- Johnson & Johnson
- Industry
- Medical Devices & Diagnostics
- Location
- Jacksonville, Florida
- Investment
- $200.0M
- Permanent jobs announced
- 100
- Status
- Under Construction
- Announced
- Jan 11, 2022
- Opening timeline
- Not yet announced
- Added to tracker
- Sep 12, 2026
Sources
Official references
- JAXUSA announcement of the Johnson & Johnson Vision expansion and incentive agreement https://jaxusa.org/news/johnson-johnson-vision-expands-jacksonville-headquarters-adding-new-jobs/
Related
Other projects to know
In Florida
Across Medical Devices & Diagnostics
Back to the tracker/projects/johnson-johnson-vision-jacksonville-2022